Literature DB >> 20872962

Mucin phenotype of gastric cancer and clinicopathology of gastric-type differentiated adenocarcinoma.

Tsutomu Namikawa, Kazuhiro Hanazaki.   

Abstract

Differentiated adenocarcinoma of the stomach is classified into gastric or intestinal phenotypes based on mucus expression. Recent advances in mucin histochemistry and immunohistochemistry have highlighted the importance of such a distinction, and it is important clinically to distinguish between gastric- and intestinal-type differentiated adenocarcinoma. However, a clinical and pathological diagnosis of this type is often difficult in early gastric cancer because of histological similarities between a hyperplastic epithelium and low-grade atypia. Furthermore, determining tumor margins is often difficult, even with extensive preoperative examination. It is therefore critical to consider these diagnostic difficulties and different biological behaviors with high malignant potential when treating patients with gastric-type differentiated adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20872962      PMCID: PMC2951512          DOI: 10.3748/wjg.v16.i37.4634

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  25 in total

1.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

Authors:  P LAUREN
Journal:  Acta Pathol Microbiol Scand       Date:  1965

Review 2.  Molecular mechanisms involved in the pathogenesis of gastric carcinoma: interactions between genetic alterations, cellular phenotype and cancer histotype.

Authors:  R Fiocca; O Luinetti; L Villani; L Mastracci; P Quilici; F Grillo; G N Ranzani
Journal:  Hepatogastroenterology       Date:  2001 Nov-Dec

3.  Tumor differentiation phenotype in gastric differentiated-type tumors and its relation to tumor invasion and genetic alterations.

Authors:  Kimiyasu Yamazaki; Yusuke Tajima; Reiko Makino; Nobukazu Nishino; Shigeo Aoki; Masanori Kato; Masaaki Sakamoto; Koji Morohara; Tsutomu Kaetsu; Mitsuo Kusano
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

4.  Relationship between biologic behavior and phenotypic expression in intramucosal gastric carcinomas.

Authors:  Akira Kabashima; Takashi Yao; Keizo Sugimachi; Masazumi Tsuneyoshi
Journal:  Hum Pathol       Date:  2002-01       Impact factor: 3.466

5.  Gastric intestinal metaplasia type III cases are classified as low-grade dysplasia on the basis of morphometry.

Authors:  P Tosi; M I Filipe; P Luzi; C Miracco; R Santopietro; R Lio; V Sforza; P Barbini
Journal:  J Pathol       Date:  1993-01       Impact factor: 7.996

6.  Gastric or intestinal phenotypic expression in the carcinomas and background mucosa of multiple early gastric carcinomas.

Authors:  A Kabashima; T Yao; K Sugimachi; M Tsuneyoshi
Journal:  Histopathology       Date:  2000-12       Impact factor: 5.087

Review 7.  Intestinal metaplasia of the stomach. A status report.

Authors:  G N Stemmermann
Journal:  Cancer       Date:  1994-07-15       Impact factor: 6.860

8.  Histochemical characterization of different types of intestinal metaplasia in gastric mucosa.

Authors:  D I Segura; C Montero
Journal:  Cancer       Date:  1983-08-01       Impact factor: 6.860

9.  Molecular mechanism of stomach carcinogenesis.

Authors:  E Tahara
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

10.  Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients.

Authors:  S Uchino; H Tsuda; K Maruyama; T Kinoshita; M Sasako; T Saito; M Kobayashi; S Hirohashi
Journal:  Cancer       Date:  1993-12-01       Impact factor: 6.860

View more
  14 in total

1.  Incidence of lymphatic involvement in differentiated-type intramucosal gastric cancers as examined by endoscopic resection.

Authors:  Yasuko Fujita; Mitsuo Kishimoto; Ryuta Nakao; Reiko Kimura-Tsuchiya; Nobuaki Yagi; Akio Yanagisawa
Journal:  Gastric Cancer       Date:  2015-02-01       Impact factor: 7.370

2.  [Standards for diagnostics and therapy of gastric cancer].

Authors:  N Schulte; M Ebert
Journal:  Internist (Berl)       Date:  2014-08       Impact factor: 0.743

Review 3.  Mitochondrial DNA alterations in the progression of gastric carcinomas: unexplored issues and future research needs.

Authors:  Luciana Rigoli; Rosario Alberto Caruso
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

4.  Gastric carcinogenesis.

Authors:  Ismail Gomceli; Baris Demiriz; Mesut Tez
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

5.  Members of the EpCAM signalling pathway are expressed in gastric cancer tissue and are correlated with patient prognosis.

Authors:  V S Warneke; H-M Behrens; J Haag; S Krüger; E Simon; M Mathiak; M P A Ebert; C Röcken
Journal:  Br J Cancer       Date:  2013-09-05       Impact factor: 7.640

6.  MET in gastric cancer--discarding a 10% cutoff rule.

Authors:  Marie-Luise Metzger; Hans-Michael Behrens; Christine Böger; Jochen Haag; Sandra Krüger; Christoph Röcken
Journal:  Histopathology       Date:  2015-07-14       Impact factor: 5.087

7.  Interpreting whole genome and exome sequencing data of individual gastric cancer samples.

Authors:  Daniela Esser; Niklas Holze; Jochen Haag; Stefan Schreiber; Sandra Krüger; Viktoria Warneke; Philip Rosenstiel; Christoph Röcken
Journal:  BMC Genomics       Date:  2017-07-06       Impact factor: 3.969

8.  Gastric mucin phenotype indicates aggressive biological behaviour in early differentiated gastric adenocarcinomas following endoscopic treatment.

Authors:  Kai Song; Qi Yang; Yu Yan; Xiaoyan Yu; Kanlun Xu; Jinghong Xu
Journal:  Diagn Pathol       Date:  2021-07-13       Impact factor: 2.644

9.  Loss of gastric gland mucin-specific O-glycan is associated with progression of differentiated-type adenocarcinoma of the stomach.

Authors:  Kazuo Shiratsu; Kayoko Higuchi; Jun Nakayama
Journal:  Cancer Sci       Date:  2013-11-22       Impact factor: 6.716

10.  Distribution of LGR5+ cells and associated implications during the early stage of gastric tumorigenesis.

Authors:  Bo Gun Jang; Byung Lan Lee; Woo Ho Kim
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.